Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
It primarily activates the GLP-1 receptor, helping patients naturally eat less without relying solely on willpower
While much of the research is still in the early stages, the findings so far are promising and suggest that these medications could play a role in treating addiction, binge eating disorder, and potentially other mental health conditions
10.1016/j.brainresrev.2009.05.005 Brain Res Rev
If a glucagon-containing triple agonist can lower A1C by roughly 2% while also driving large weight loss, then the GLP-1 and GIP arms are clearly counterbalancing glucagons tendency to raise glucose
Ele atua de duas formas principais: estimulando a secreo de insulina pelo pncreas em resposta glicose e retardando o esvaziamento gstrico, prolongando a saciedade aps as refeies
